Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmunoVision is a specialized biotechnology company focused on the development and manufacture of reagents for autoimmune disease research and diagnostics. Established in 1987 and headquartered in Springdale, Arkansas, the company is a global leader in providing purified autoantigens, antibodies, and diagnostic kits. Their product portfolio is essential for the detection of rheumatic diseases, including Systemic Lupus Erythematosus and Sjögren's Syndrome. ImmunoVision specializes in the purification of native antigens and the production of high-quality recombinant proteins. The company serves clinical laboratories, academic researchers, and pharmaceutical companies worldwide. Currently operating as a subsidiary of Euroimmun, a Revvity company, ImmunoVision continues to set industry standards for biological reagents in the field of immunology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImmunoVision.